Author + information
- Received May 24, 2010
- Accepted June 11, 2010
- Published online September 1, 2010.
- Scot Garg, MB, ChB⁎,
- Gregg W. Stone, MD, PhD‡,
- Arie-Peter Kappetein, MD, PhD†,
- Joseph F. Sabik III, MD§,
- Charles Simonton, MD∥ and
- Patrick W. Serruys, MD, PhD⁎,⁎ ()
- ↵⁎Reprint requests and correspondence:
Prof. Patrick W. Serruys, Ba583a, Thoraxcenter, Erasmus Medical Center, 's-Gravendijkwal 230, Rotterdam 3015 CE, the Netherlands
Percutaneous coronary intervention of unprotected left main stem lesions has been shown to be a suitable alternative to cardiac surgery in selected patients, emphasizing the need for appropriate risk stratification prior to selection of revascularization modality. Several risk models based on clinical and angiographic variables have been developed to guide patient selection, each of which has significant limitations. This paper reviews contemporary and newly proposed risk models for patients undergoing left main stem revascularization.
- ACEF score
- clinical SYNTAX score
- coronary artery bypass grafting
- global risk classification
- percutaneous coronary intervention
- SYNTAX score
- unprotected left main stem
Dr. Stone a member of the scientific advisory board of Boston Scientific and Abbott Vascular. Dr. Kappetein is a member of the Steering Committee in a trial funded by Boston Scientific and in a trial funded by Abbott Vascular. Dr. Sabik is a consultant for Medtronic, Inc. and has received speaker fees from Edwards Lifesciences. Dr. Simonton is a Chief Medical Officer for Abbott Vascular. All other authors report that they have no relationships to disclose. This manuscript follows a similarly titled presentation given by Patrick W. Serruys at the American College of Cardiology meeting in Atlanta 2010.
- Received May 24, 2010.
- Accepted June 11, 2010.
- American College of Cardiology Foundation
- Does the ULM Need Revascularization?
- Is There a Need for Risk Stratification in ULM Revascularization?
- What Methods of Risk Stratification Are Available for Patients With ULM Lesions?
- Clinical-Based Scores
- Angiographic-Based Scores
- Combined Risk Scores
- Limitations of Risk Models